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0ORRESPONDENCEhe Importance of Incident Depression in Myocardial
nfarction Patients
o the Editor:
Depression that is present in the aftermath of a myocardial
nfarction (MI), post-MI depression, may encompass different
ubtypes based on whether it is the first or a recurrent episode
nd based on its onset (i.e., started before or after the MI).
ncident post-MI depression is defined as a first-ever episode
ith an onset after the MI. In a recent issue of Biological
sychiatry, Parker et al. (1) confirm that the association between
ost-MI depression and prospective cardiovascular events is due
o those episodes that develop just after the cardiac event.
Although some still believe the results in this area of research
re inconclusive (2), summarizing the evidence reveals there is
nly one relatively small study (n  222) from 1996 by Lesper-
nce et al. (3) suggesting that recurrent depression is associated
ith an increased risk of cardiac events. In contrast, there are
our larger and more recent studies, namely by Grace et al. (4)
n  750), de Jonge et al. (5) (n  468), Dickens et al. (6) (n 
88), and recently the study by Parker et al. (1) (n  489),
uggesting that it is incident depression that is most strongly
ssociated with prospective cardiovascular events. Apart from
he larger sample sizes of these more recent studies, it is
mportant to note that the estimated increased risk of post-MI
epression on survival has dramatically decreased from the early
tudies by Frasure-Smith et al. (7) (hazard ratio [HR]  5.8,
nadjusted effect) to more recent, meta-analytic based estima-
ions of around 2 (van Melle et al. [8]: HR  2.4; Nicholson et al.
9]: HR  1.8; Barth et al. [10]: HR  2.2). As a result, the earlier
tudies may no longer accurately reflect the actual risk.
Some recent studies have also shown that incident depression
s associated with aspects of MI severity (11) and coronary artery
isease (CAD) severity (12), suggesting a different etiology than
ecurrent depression. This is not to say that post-MI depression is
ecessarily an artifact, although in part it may be, but at least that
t may be a specific kind of reaction that is different from normal
epression. Among the possible mechanisms of how post-MI
epression may lead to impaired cardiovascular prognosis, the
ole of inflammation and low heart rate variability have been
roposed (13). Both are associated with the severity of the
nderlying heart disease, depression, and cardiovascular prog-
osis. Of interest, both increased inflammation (14) and de-
reased heart rate variability (15) are specifically associated with
omatic, rather than cognitive, symptoms of depression, which
ay be more prevalent in incident depression. In other words,
ncident post-MI depression may be a condition in which depres-
ion and heart disease are truly intertwined.
The finding that incident post-MI depression, relative to
ecurrent depression, is distinctively associated with subsequent
egative cardiac outcomes is of utmost interest with respect to
reatment options. The presence of incident post-MI depression
ay help to explain the disappointing results from intervention
rials aimed to treat post-MI depression and thereby attempting to
mprove cardiovascular prognosis (16–18). Thus far, the distinc-
ion between incident depression and recurrent depression has
een found helpful in distinguishing response to treatment in
on-CAD depressed patients (19–21), in which only subjects
ho had repeated past episodes responded to therapy. With the
esults presented by Parker et al. (1), it is possible that in MI
atients, we are currently able to effectively treat depression that
s not associated with an increased risk of cardiovascular events
ut not depression that is associated with increased risk, as
006-3223/09/$36.00observed in the Sertraline AntiDepressant Heart Attack Trial
(SADHART) (16). The result is a failure to improve cardiovascular
prognosis by treating post-MI depression as observed in the
Enhancing Recovery in Coronary Heart Disease Patients, or
ENRICHD, trial (17), and the Myocardial INfarction and Depres-
sion Intervention Trial, or MIND-IT (18). The presence of inci-
dent post-MI depression therefore urges us to keep our eyes
open to new developments in this rapidly expanding area of
research and to develop new interventions that might be quite
different than what has been tried before.
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